menu
    • menu

    Company profile for ArcherDX, Inc

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ArcherDx, Inc., a molecular technology company, develops solutions that advance the application of personalized genomic medicine. The company offers solid tumor assays, blood cancer assays, sarcoma kits, next-gen NTRK fusion detection products, immunity assays, and other products. The company was incorporated in 2013 and is based in Boulder, Colorado.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ArcherDX, IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2477 55th Street, Suite 202 Boulder, CO 80301
    Telephone
    Telephone
    (877) 771 1093
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://archerdx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/archerdx
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/archerdxinc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hematogenix Unites With 19 Organizations from the Healthcare Community
    Hematogenix Unites With 19 Organizations from the Healthcare Community

    05 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/hematogenix-unites-with-19-organizations-from-the-healthcare-community-to-form-covid-19-testing-industry-consortium-301145905.html

    PRNEWSWIRE
    05 Oct 2020
    Share Share
    ArcherDX drops IPO plans in favor of a $1.4B takeover by Invitae
    ArcherDX drops IPO plans in favor of a $1.4B takeover by Invitae

    24 Jun 2020

    // Conor Hale FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/archerdx-drops-ipo-plans-favor-a-1-4b-takeover-by-invitae

    Conor Hale FIERCE BIOTECH
    24 Jun 2020
    Share Share
    Personalized cancer test maker ArcherDX files $100M IPO
    Personalized cancer test maker ArcherDX files $100M IPO

    08 Jun 2020

    // Conor Hale FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/personalized-cancer-test-maker-archerdx-files-100m-ipo

    Conor Hale FIERCE BIOTECH
    08 Jun 2020
    Share Share
    AZ links with ArcherDX to detect minimal residual disease in lung cancer patient
    AZ links with ArcherDX to detect minimal residual disease in lung cancer patient

    25 May 2020

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/az_links_with_archerdx_to_detect_minimal_residual_disease_in_lung_cancer_patients_1340872

    Selina McKee PHARMA TIMES
    25 May 2020
    Share Share
    Bayer and ArcherDX Announce Global Collaboration to Develop (NGS)
    Bayer and ArcherDX Announce Global Collaboration to Develop (NGS)

    14 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200514005222/en

    BUSINESSWIRE
    14 May 2020
    Share Share
    ArcherDX and Ayala Pharmaceuticals Announce Collaboration
    ArcherDX and Ayala Pharmaceuticals Announce Collaboration

    11 Jul 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/archerdx-and-ayala-pharmaceuticals-announce-strategic-companion-diagnostic-collaboration-300880320.html

    PR NEWSWIRE
    11 Jul 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search